*Correspondence: Lei Xu, [email protected] Liu, [email protected] These authors have contributed equally to this work This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A meta-analysis of 21 double-blind clinical trials concluded that acetyl-L-carnitine treatment in patients with mild cognitive impairment and mild Alzheimer's disease demonstrated significant efficacy versus placebo in improving cognitive function, particularly in domains of logical intelligence, verbal memory, selective attention, and functional capacity
5 Likes Steve_Combi January 31, 2026, 7:51pm #32 To find my dose I started at 250 and increased until I could see the difference
However, their exact effects remain unclear
Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat
WHY WEGOVY IS PREFERRED The CVS Caremark Connection The CVS Caremark Connection Understanding why Wegovy is Aetna's preferred GLP-1 helps explain your coverage options
